BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/20/2025 3:37:28 AM | Browse: 126 | Download: 356
Publication Name World Journal of Clinical Oncology
Manuscript ID 102223
Country China
Received
2024-10-12 06:19
Peer-Review Started
2024-10-12 06:19
First Decision by Editorial Office Director
2025-01-03 09:48
Return for Revision
2025-01-03 09:48
Revised
2025-02-10 14:34
Publication Fee Transferred
Second Decision by Editor
2025-02-19 02:44
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2025-02-19 07:35
Articles in Press
2025-02-19 07:35
Edit the Manuscript by Language Editor
Typeset the Manuscript
2025-03-10 00:54
Publish the Manuscript Online
2025-05-20 03:37
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Editorial
Article Title East meets West: The winning combination against BRAF V600E metastatic colorectal cancer
Manuscript Source Invited Manuscript
All Author List Wen-Ming Liu and Xiao-Bing Li
ORCID
Author(s) ORCID Number
Xiao-Bing Li http://orcid.org/0000-0002-3332-0575
Funding Agency and Grant Number
Funding Agency Grant Number
Natural Science Foundation of Hubei Province No. 2019CFC929
Corresponding Author Xiao-Bing Li, Assistant Professor, MD, PhD, Department of Thoracic Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 116 South Zhuodaoquan Road, Hongshan District, Wuhan 430079, Hubei Province, China. lixiaobing0629@126.com
Key Words Traditional Chinese medicine; Western medicine; BRAF mutation; Metastatic colorectal cancer; Medicine
Core Tip Bian et al’s study demonstrates that integrated treatment with tolerated toxicity significantly improves survival in patients with BRAF mutant advanced colorectal cancer compared to traditional Western medicine alone, especially for certain subgroups. However, while this study provides new evidence supporting combined therapies, it also has limitations, such as unclear mechanisms of action, lack of detailed treatment protocols, and a small sample size. Summarizing these new findings and addressing the study’s issues will not only aid in the clinical application of integrated treatments for colorectal cancer but also promote the development of personalized therapies for this disease.
Publish Date 2025-05-20 03:37
Citation

Liu WM, Li XB. East meets West: The winning combination against BRAF V600E metastatic colorectal cancer. World J Clin Oncol 2025; 16(5): 102223

URL https://www.wjgnet.com/2218-4333/full/v16/i4/102223.htm
DOI https://dx.doi.org/10.5306/wjco.v16.i4.102223
Manuscript File 102223_Auto_Edited_033350.docx
Answering Reviewers 102223-answering-reviewers.pdf
Audio Core Tip 102223-audio.m4a
Conflict-of-Interest Disclosure Form 102223-conflict-of-interest-statement.pdf
Copyright License Agreement 102223-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate 102223-non-native-speakers.pdf
Peer-review Report 102223-peer-reviews.pdf
Scientific Misconduct Check 102223-scientific-misconduct-check.png
Scientific Editor Work List 102223-scientific-editor-work-list.pdf
CrossCheck Report 102223-crosscheck-report.pdf